Terms: = Skin cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
23 results:
1. [Effect of acetylalkannin from Arnebia euchroma on proliferation, migration, and invasion of human melanoma A375 cells].
Kang YY; Qian Q; Yang Y; Yang Y; Xu F; Li M; Li JG
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5049-5055. PubMed ID: 37802847
[TBL] [Abstract] [Full Text] [Related]
2. Germline genomic findings in children and young adults with melanocytic tumors.
Nagel MB; Perrino MR; Nuccio R; Blake AK; Harrison L; Nichols KE; Pappo AS
Pediatr Blood Cancer; 2023 Jul; 70(7):e30361. PubMed ID: 37073685
[TBL] [Abstract] [Full Text] [Related]
3. axin2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Leclerc J; Beaumont M; Vibert R; Pinson S; Vermaut C; Flament C; Lovecchio T; Delattre L; Demay C; Coulet F; Guillerm E; Hamzaoui N; Benusiglio PR; Brahimi A; Cornelis F; Delhomelle H; Fert-Ferrer S; Fournier BPJ; Hovnanian A; Legrand C; Lortholary A; Malka D; Petit F; Saurin JC; Lejeune S; Colas C; Buisine MP
Genes Chromosomes Cancer; 2023 Apr; 62(4):210-222. PubMed ID: 36502525
[TBL] [Abstract] [Full Text] [Related]
4. A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.
Oh Y; Zheng Z; Kim KY; Xu X; Pei M; Oh B; Kim SK; Chung KY; Roh MR
BMC Cancer; 2022 Nov; 22(1):1126. PubMed ID: 36324094
[TBL] [Abstract] [Full Text] [Related]
5. Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells.
Jia Q; Tao L; Zhou Y; Song L; Wei Z; Lu T; Woodgett JR; Lu Y
J Dermatol Sci; 2022 Jun; 106(3):170-180. PubMed ID: 35641396
[TBL] [Abstract] [Full Text] [Related]
6. Model-based dose selection to inform translational clinical oncology development of WNT974, a first-in-class Porcupine inhibitor.
Ji Y; Huang PH; Woolfenden S; Myers A
Clin Transl Sci; 2022 Jul; 15(7):1713-1722. PubMed ID: 35620969
[TBL] [Abstract] [Full Text] [Related]
7. Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Rodon J; Argilés G; Connolly RM; Vaishampayan U; de Jonge M; Garralda E; Giannakis M; Smith DC; Dobson JR; McLaughlin ME; Seroutou A; Ji Y; Morawiak J; Moody SE; Janku F
Br J Cancer; 2021 Jul; 125(1):28-37. PubMed ID: 33941878
[TBL] [Abstract] [Full Text] [Related]
8. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
Kim GH; Fang XQ; Lim WJ; Park J; Kang TB; Kim JH; Lim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933177
[TBL] [Abstract] [Full Text] [Related]
9. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human cancers.
Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
[TBL] [Abstract] [Full Text] [Related]
10. Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β-catenin and matrix metallopeptidase 9.
Zhang P; Zhang M; Yu D; Liu W; Hu L; Zhang B; Zhou Q; Cao Z
J Cell Physiol; 2019 Jul; 234(7):10566-10575. PubMed ID: 30565685
[TBL] [Abstract] [Full Text] [Related]
11. The Effect of Phototherapy on cancer Predisposition Genes of Diabetic and Normal Human skin Fibroblasts.
Chotikasemsri P; Tangtrakulwanich B; Sangkhathat S
Biomed Res Int; 2017; 2017():7604861. PubMed ID: 28386563
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
[TBL] [Abstract] [Full Text] [Related]
13. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
[TBL] [Abstract] [Full Text] [Related]
14. Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.
Xia Y; Wu S
Cell Cycle; 2015; 14(11):1666-74. PubMed ID: 25839957
[TBL] [Abstract] [Full Text] [Related]
15. PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma.
Saito T; Mitomi H; Imamhasan A; Hayashi T; Kurisaki-Arakawa A; Mitani K; Takahashi M; Kajiyama Y; Yao T
Mutagenesis; 2015 Mar; 30(2):297-301. PubMed ID: 25395299
[TBL] [Abstract] [Full Text] [Related]
16. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
[TBL] [Abstract] [Full Text] [Related]
17. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
[TBL] [Abstract] [Full Text] [Related]
18. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract] [Full Text] [Related]
19. The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.
Bonilla-Delgado J; Bulut G; Liu X; Cortés-Malagón EM; Schlegel R; Flores-Maldonado C; Contreras RG; Chung SH; Lambert PF; Uren A; Gariglio P
Mol Cancer Res; 2012 Feb; 10(2):250-8. PubMed ID: 22160870
[TBL] [Abstract] [Full Text] [Related]
20. AXIS inhibition protein 2, orofacial clefts and a family history of cancer.
Menezes R; Marazita ML; Goldstein McHenry T; Cooper ME; Bardi K; Brandon C; Letra A; Martin RA; Vieira AR
J Am Dent Assoc; 2009 Jan; 140(1):80-4. PubMed ID: 19119171
[TBL] [Abstract] [Full Text] [Related]
[Next]
